November 2, 2024 Tech Titans’ Mixed Results Stall Wall Street Bull Run
October 28, 2024 Recent Oil Slides In Global Markets, Japan In Flux
Microsoft: The Party Is Coming To An End
Apple Q4: Further Risk To Near-Term China Estimate?
Apple: Berkshire Sales And Slow Revenue Raise Concerns
AMZN: Wall Street’s Most Loved Stock May Be A Growth Trap
October 22, 2024 A Comprehensive Guide to RoadRunner Auto Transport Services
October 3, 2024 Mastering Trading Indicators: Your Essential Toolkit For Success
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
Calliditas Therapeutics (CALT) stock forecast for 2025
Updated: November 6, 2024 (04:16)
Sector: HealthcareThe share price of Calliditas Therapeutics AB (publ) (CALT) now
50/200 Day Moving Average: $39.65 / $29.6
This figure corresponds to the Average Price over the previous 50/200 days. For Calliditas Therapeutics stocks, the 50-day moving average is the resistance level today.
For Calliditas Therapeutics stocks, the 200-day moving average is the resistance level today.
Are you interested in Calliditas Therapeutics AB (publ) stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Calliditas Therapeutics stock price in 2025. How much will one Calliditas Therapeutics share be worth in 2025? Is it worth taking profit / loss on CALT stock now or waiting? What are analysts' forecasts for Calliditas Therapeutics stock?
We forecast Calliditas Therapeutics stock performance using neural networks based on historical data on CALT stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Calliditas Therapeutics AB (publ) stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Calliditas Therapeutics analysts is $39.25. Today 200 Day Moving Average is the support level (29.6 $). 50 Day Moving Average is the support level (39.65 $).
Historical and forecast chart of Calliditas Therapeutics AB (publ) stock
The chart below shows the historical price of Calliditas Therapeutics stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the CALT stock price can be found in the table below.
Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, has focused on identifying, developing and commercializing pharmaceutical products for the treatment of orphan symptoms with an initial focus on kidney and liver diseases. The main candidate for the company’s products is Nefekon, an oral budesonide drug that is an immunosuppressive agent for the treatment of autoimmune IgA renal nephropathy. Calliditas Therapeutics AB (publ) was founded in 2004 and is headquartered in Stockholm, Sweden.
Calliditas Therapeutics (CALT) Forecast for 2025
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 42.74 | 36.41 | 47.45 | 23.28 % |
Feb | 43.23 | 38.96 | 48.40 | 19.51 % |
Mar | 35.59 | 30.79 | 37.82 | 18.59 % |
Apr | 29.50 | 27.88 | 30.68 | 9.14 % |
May | 34.38 | 32.94 | 37.06 | 11.10 % |
Jun | 32.23 | 30.14 | 33.69 | 10.54 % |
Jul | 29.90 | 26.77 | 33.88 | 20.96 % |
Aug | 27.23 | 23.92 | 30.80 | 22.34 % |
Sep | 29.30 | 28.18 | 31.36 | 10.12 % |
Oct | 29.35 | 27.96 | 33.03 | 15.36 % |
Nov | 25.34 | 23.80 | 26.98 | 11.78 % |
Dec | 29.77 | 28.47 | 31.12 | 8.54 % |
Calliditas Therapeutics information and performance
KUNGSBRON 1, C8, STOCKHOLM, SE
Market capitalization of the Calliditas Therapeutics AB (publ) is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CALT shares in the company outstanding by the market price of one share.
EBITDA of Calliditas Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Calliditas Therapeutics price target for 2025 by month
Target values for the price of one Calliditas Therapeutics share for Jan 2025.
In Jan, the Positive dynamics for Calliditas Therapeutics AB (publ) shares will prevail with possible monthly volatility of 23.275% volatility is expected.
Pessimistic target level: 36.41
Optimistic target level: 47.45
Target values for the price of one Calliditas Therapeutics share for Feb 2025.
In Feb, the Positive dynamics for Calliditas Therapeutics AB (publ) shares will prevail with possible monthly volatility of 19.514% volatility is expected.
Pessimistic target level: 38.96
Optimistic target level: 48.40
Target values for the price of one Calliditas Therapeutics share for Mar 2025.
In Mar, the Negative dynamics for Calliditas Therapeutics AB (publ) shares will prevail with possible monthly volatility of 18.594% volatility is expected.
Pessimistic target level: 30.79
Optimistic target level: 37.82
Target values for the price of one Calliditas Therapeutics share for Apr 2025.
In Apr, the Negative dynamics for Calliditas Therapeutics AB (publ) shares will prevail with possible monthly volatility of 9.136% volatility is expected.
Pessimistic target level: 27.88
Optimistic target level: 30.68
Target values for the price of one Calliditas Therapeutics share for May 2025.
In May, the Positive dynamics for Calliditas Therapeutics AB (publ) shares will prevail with possible monthly volatility of 11.105% volatility is expected.
Pessimistic target level: 32.94
Optimistic target level: 37.06
Target values for the price of one Calliditas Therapeutics share for Jun 2025.
In Jun, the Negative dynamics for Calliditas Therapeutics AB (publ) shares will prevail with possible monthly volatility of 10.540% volatility is expected.
Pessimistic target level: 30.14
Optimistic target level: 33.69
Target values for the price of one Calliditas Therapeutics share for Jul 2025.
In Jul, the Negative dynamics for Calliditas Therapeutics AB (publ) shares will prevail with possible monthly volatility of 20.962% volatility is expected.
Pessimistic target level: 26.77
Optimistic target level: 33.88
Target values for the price of one Calliditas Therapeutics share for Aug 2025.
In Aug, the Negative dynamics for Calliditas Therapeutics AB (publ) shares will prevail with possible monthly volatility of 22.341% volatility is expected.
Pessimistic target level: 23.92
Optimistic target level: 30.80
Target values for the price of one Calliditas Therapeutics share for Sep 2025.
In Sep, the Positive dynamics for Calliditas Therapeutics AB (publ) shares will prevail with possible monthly volatility of 10.119% volatility is expected.
Pessimistic target level: 28.18
Optimistic target level: 31.36
Target values for the price of one Calliditas Therapeutics share for Oct 2025.
In Oct, the Positive dynamics for Calliditas Therapeutics AB (publ) shares will prevail with possible monthly volatility of 15.363% volatility is expected.
Pessimistic target level: 27.96
Optimistic target level: 33.03
Target values for the price of one Calliditas Therapeutics share for Nov 2025.
In Nov, the Negative dynamics for Calliditas Therapeutics AB (publ) shares will prevail with possible monthly volatility of 11.779% volatility is expected.
Pessimistic target level: 23.80
Optimistic target level: 26.98
Target values for the price of one Calliditas Therapeutics share for Dec 2025.
In Dec, the Positive dynamics for Calliditas Therapeutics AB (publ) shares will prevail with possible monthly volatility of 8.540% volatility is expected.
Pessimistic target level: 28.47
Optimistic target level: 31.12
Related stocks from Healthcare sector